Chinese metabolic syndrome risk score

Southern Medical Journal

Volumn 102, Issue 2, 2009, Pages 159-164

  Hsiao, Fone Ching ^b   Wu, Chung Ze ^b   Hsieh, Chang Hsun ^b   He, Chih Tsueng ^b   Hung, Yi Jen ^b   Pei, Dee ^a  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b NONE

Author keywords

Metabolic syndrome; Risk score; Triglycerides; Waist circumference

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC SYNDROME X; RISK ASSESSMENT; ROC CURVE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; MIDDLE AGED; PREDICTION AND FORECASTING; QUESTIONNAIRE; STATISTICAL MODEL; TAIWAN;

ADULT; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 63249122964     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181836b19     Document Type: Article

References (23)

1. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752.
2. Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142: 611-619.
3. Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005;28:888-894.
4. Reaven GM, Chen YD. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 1988;4:639-652.
5. Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-422.
6. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486 -2497.
7. Saad MF, Rewers M, Selby J, et al. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension 2004;43:1324 -1331.
8. Toft I, Bonaa KH, Jenssen T. Insulin resistance in hypertension is associated with body fat rather than blood pressure. Hypertension 1998; 32:115-122.
9. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003;32:855- 867.
10. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007;176:1113-1120.
11. Cheal KL, Abbasi F, Lamendola C, et al. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004;53:1195-1200.
12. Hsieh CH, Hung YJ, Wu DA, et al. Impact of clinical characteristics of individual metabolic syndrome on the severity of insulin resistance in Chinese adults. J Korean Med Sci 2007;22:74-80.
13. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439 - 451.
14. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801.
15. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881- 887.
16. Laaksonen DE, Lakka HM, Salonen JT, et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002;25:1612-1618.
17. Raikkonen K, Matthews KA, Kuller LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions [Erratum in Diabetes Care 2007;30:2761]. Diabetes Care 2007;30: 872- 877.
18. Mohan V, Sandeep S, Deepa M, et al. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab 2007;9:337-343.
19. Saaristo T, Peltonen M, Lindstrom J, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005;2:67-72.
20. Heldgaard PE, Griffin SJ. Routinely collected general practice data aids identification of people with hyperglycaemia and metabolic syndrome. Diabet Med 2006;23:996 -1002.
21. Lamarche B, Tchernof A, Mauriege P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998;279:1955-1961.
22. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-184.
23. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001;322:716 -720.